Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2022
Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked HypophosphatemiaLeanne M Ward, Francis H Glorieux, Michael P Whyte, et al.
JBMR Plus|May 1, 2024
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension periodLeanne M Ward, Wolfgang Högler, Francis H Glorieux, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2023
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose LevelErik A Imel, Francis H Glorieux, Michael P Whyte, et al.
Human Molecular Genetics|April 2, 2009
SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathwaySimon T Cliffe, Jamie M Kramer, Khalid Hussain, et al.
Calcified Tissue International|January 23, 2021
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked HypophosphatemiaRaja Padidela, Michael P Whyte, Francis H Glorieux, et al.
European Journal of Endocrinology|June 23, 2026
Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemiaSigne Sparre Beck-Nielsen, Gema Ariceta, Annemieke M Boot, et al.
The Journal of Clinical Endocrinology and Metabolism|February 10, 2012
Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasiaTaneli Raivio, Magdalena Avbelj, Mark J McCabe, et al.
Lancet (London, England)|May 21, 2019
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trialErik A Imel, Francis H Glorieux, Michael P Whyte, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2016
Comprehensive Screening of Eight Known Causative Genes in Congenital Hypothyroidism With Gland-in-SituAdeline K Nicholas, Eva G Serra, Hakan Cangul, et al.
The Journal of Clinical Investigation|November 19, 2010
Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humansErik Schoenmakers, Maura Agostini, Catherine Mitchell, et al.
Pageof 9